These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 26281150
1. Early De Novo Donor Specific Antibody Involvement in Delayed Graft Function After Kidney Transplantation: A Report of 2 Cases. Zhu L, Chen G, Zhang W, Guo H, Lin Z, Du D, Chen S, Shi H, Liu S, Chen Z. Clin Transpl; 2014; ():231-4. PubMed ID: 26281150 [Abstract] [Full Text] [Related]
2. Differential Impact of Delayed Graft Function in Deceased Donor Renal Transplant Recipients With and Without Donor-specific HLA-antibodies. Haller J, Wehmeier C, Hönger G, Hirt-Minkowski P, Gürke L, Wolff T, Steiger J, Amico P, Dickenmann M, Schaub S. Transplantation; 2019 Sep; 103(9):e273-e280. PubMed ID: 31205266 [Abstract] [Full Text] [Related]
3. Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation. Morath C, Döhler B, Kälble F, Pego da Silva L, Echterdiek F, Schwenger V, Živčić-Ćosić S, Katalinić N, Kuypers D, Benöhr P, Haubitz M, Ziemann M, Nitschke M, Emmerich F, Pisarski P, Karakizlis H, Weimer R, Ruhenstroth A, Scherer S, Tran TH, Mehrabi A, Zeier M, Süsal C. Front Immunol; 2020 Sep; 11():1886. PubMed ID: 32983110 [Abstract] [Full Text] [Related]
4. Influence of de novo donor-specific antibody on early renal allograft function recovery. Zheng J, Xue W, Jing X, Hou J, Tian X, Tian P, Ding X, Pan X, Yan H, Feng X, Xiang H, Li Y, Ding C. Ren Fail; 2015 Apr; 37(3):462-8. PubMed ID: 25697229 [Abstract] [Full Text] [Related]
6. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients. Zhu D, Qi G, Tang Q, Li L, Yang C, Lin M, Wu B, Xu M, Cai J, Zhu T, Rong R. Clin Transpl; 2014 Apr; ():215-21. PubMed ID: 26281148 [Abstract] [Full Text] [Related]
7. De novo donor specific antibodies and patient outcomes in renal transplantation. DeVos JM, Patel SJ, Burns KM, Dilioglou S, Gaber LW, Knight RJ, Gaber AO, Land GA. Clin Transpl; 2011 Apr; ():351-8. PubMed ID: 22755430 [Abstract] [Full Text] [Related]
12. Delayed graft function in living-donor renal transplantation: 10-year experience. Park HS, Hong YA, Kim HG, Choi SR, Sun IO, Chung BH, Choi BS, Park CW, Kim YS, Yang CW. Transplant Proc; 2012 Jan; 44(1):43-6. PubMed ID: 22310574 [Abstract] [Full Text] [Related]
13. Efficacy of immunoadsorption to reduce donor-specific alloantibodies in kidney-transplant candidates. Rostaing L, Congy N, Aarnink A, Maggioni S, Allal A, Sallusto F, Game X, Kamar N. Exp Clin Transplant; 2015 Apr; 13 Suppl 1():201-6. PubMed ID: 25894155 [Abstract] [Full Text] [Related]
14. Pre-transplant donor-specific anti-human leukocyte antigen antibodies are associated with high risk of delayed graft function after renal transplantation. Peräsaari JP, Kyllönen LE, Salmela KT, Merenmies JM. Nephrol Dial Transplant; 2016 Apr; 31(4):672-8. PubMed ID: 26614272 [Abstract] [Full Text] [Related]
16. Highly Sensitized Patients: Miami Transplant Institute Experience. Mattiazzi AD, Centeno A, Amador A, Fernandez-Bango C, Scowby CD, O'Rourke M, Hill-Matthie T, Patel R, Barrios F, Ruiz P, Chen L, Saghesima J, Ciancio G, Burke GW, Goldstein M, Chandar J, Contreras G, Roth D, Kupin W, Guerra G, Vianna R. Clin Transpl; 2014 Apr; ():171-8. PubMed ID: 26281142 [Abstract] [Full Text] [Related]
17. The Role of Donor-Specific Antibodies in Intestinal Transplantation: Experience at the University of California Los Angeles and Literature Review. Cheng EY, Kaneku H, Farmer DG. Clin Transpl; 2014 Apr; ():153-9. PubMed ID: 26281140 [Abstract] [Full Text] [Related]
20. Impact of HLA antibodies on graft survival in long-term renal recipients with functional grafts. Zeng Y, Liu Z, Liu Y, Fan Y, Guo Y, Qiu J. Urol Int; 2014 Apr; 92(3):328-33. PubMed ID: 24480999 [Abstract] [Full Text] [Related] Page: [Next] [New Search]